Listed

Celularity Inc: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Mar 4, 2021 and accepted by EDGAR at Mar 3, 2021, 17:55 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income12 months2020-01-01 to 2020-12-31−$4.2mus-gaap:OperatingIncomeLoss
Income tax12 months2020-01-01 to 2020-12-31$191.6kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2020-01-01 to 2020-12-31−$2.6mus-gaap:NetIncomeLoss
Diluted EPS12 months2020-01-01 to 2020-12-31−$0.45us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2020-01-01 to 2020-12-31−$1.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2020-12-31$314.7kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$359.3kus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$292.2mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$3.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$14.2mus-gaap:Liabilities
Shareholders' equityAt period end2020-12-31$5.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-21-013228. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.